Article
Construction of a prognostic model for gastric cancer based on immune infiltration and microenvironment, and exploration of MEF2C gene function
14 Jan 2025
Abstract excerpt
Advanced gastric cancer (GC) exhibits a high recurrence rate and a dismal prognosis. Myocyte enhancer factor 2c ( MEF2C ) was found to contribute to the development of various types of cancer. Therefore, our aim is to develop a prognostic model that predicts the prognosis of GC patients and initially explore the role of MEF2C in immunotherapy for GC. Transcriptome sequence data of GC was obtained from The Cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
